Keyphrases
Analytical Performance
21%
Androgens
18%
Antiphospholipid Antibodies
19%
Antiphospholipid Syndrome
21%
Autoantibodies
49%
Binding Properties
16%
C-terminal Agrin Fragment
33%
Cardiolipin
15%
Central Laboratory
33%
Chemiluminescent Enzyme Immunoassay (CLEIA)
34%
Clinical Application
27%
Clinical Chemistry
22%
Clinical Laboratory
17%
Clinically Significant
16%
Coproporphyrin
24%
Dehydroepiandrosterone Sulfate (DHEAS)
19%
Depressed Patients
19%
Elecsys
22%
External Quality Assessment
18%
Fetuin-A
18%
Germany
34%
Glycoprotein
27%
Hemoglobin A1c (HbA1c)
16%
Immunoassay
52%
Immunosensor
20%
Ketoconazole
16%
Kidney Function
16%
Laboratory Diagnosis
23%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
20%
Menopausal Transition
16%
Monoclonal Antibody
23%
Multicentre Evaluation
17%
Near-patient
21%
Perimenopausal
16%
Perimenopause
22%
Point-of-care
47%
Point-of-care Testing
100%
Polycystic Ovary Syndrome
17%
Postmenopausal Women
16%
Preanalytical Phase
18%
Quality Assurance
20%
Serum Concentration
30%
Serum Levels
21%
Sex Hormone-binding Globulin
58%
Surface Plasmon Resonance Sensor
29%
Testosterone
39%
Therapeutic Drug Monitoring
22%
Toll-like
17%
Type 1 Diabetes Mellitus (T1DM)
20%
β2-glycoprotein I (β2GPI)
29%
Medicine and Dentistry
Agrin
11%
Alkaline Phosphatase
10%
Androgen
16%
Antiphospholipid Antibody
11%
Autoantibodies
8%
Biological Marker
8%
Blood Gas
12%
Blood Gas Analysis
13%
Blood Glucose
20%
Bone Density
18%
Bone Metabolism
13%
Cancellous Bone
8%
Carboxy Terminal Sequence
11%
Cardiolipin
11%
Chronic Kidney Disease
11%
Climacterium
29%
Clinical Medicine
6%
Deoxypyridinoline
6%
Diabetes
12%
Diabetes Mellitus
19%
Diagnosis
29%
Diagnostic Performance
7%
Disease
16%
Fetuin A
12%
First Trimester Pregnancy
11%
Glycoprotein
11%
Health Care Cost
15%
Hemoglobin A1c
12%
Hyperandrogenism
7%
Hypoalbuminemia
7%
Infusion
6%
Kidney Function
15%
Laboratory Medicine
15%
Ossification
9%
Osteocalcin
10%
Osteolysis
21%
Ovulation
7%
Point-of-Care Testing
67%
Postmenopause
17%
Postoperative Complication
10%
Premenopause
12%
Progesterone
7%
Prospective Study
8%
Pyridinoline
8%
Secondary Amenorrhea
11%
Sex Hormone Binding Globulin
25%
Surface Enhanced Raman Spectroscopy
11%
Surgical Risk
8%
Symptom
11%
Therapeutic Drug Monitoring
7%
